HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph A Fraietta Selected Research

tisagenlecleucel

2/2024Reinfusion of CD19 CAR T Cells for Relapse Prevention and Treatment in Children with Acute Lymphoblastic Leukemia.
10/2018Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell.
1/2016The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph A Fraietta Research Topics

Disease

37Neoplasms (Cancer)
04/2024 - 01/2014
9B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2023 - 03/2016
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2024 - 03/2016
5Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 11/2020
4Multiple Myeloma
12/2023 - 01/2014
4Prostatic Neoplasms (Prostate Cancer)
11/2022 - 01/2018
3Glioblastoma (Glioblastoma Multiforme)
10/2021 - 02/2015
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 01/2018
3Infections
12/2014 - 10/2010
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2024 - 01/2016
2Residual Neoplasm
02/2024 - 01/2023
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2024 - 12/2023
2Disease Progression
01/2019 - 01/2013
2Leukemia
10/2018 - 03/2016
1Cytopenia
03/2024
1cell-associated neurotoxicity
03/2024
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2024
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2023
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2022
1Lymphoma (Lymphomas)
10/2022
1Cytokine Release Syndrome
01/2022
1COVID-19
01/2022
1Sepsis (Septicemia)
01/2022
1Blister (Bulla)
12/2020
1Pemphigus (Pemphigus Vulgaris)
12/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2016
1Fibrosis (Cirrhosis)
04/2016
1Bacterial Infections (Bacterial Infection)
02/2016
1Acquired Immunodeficiency Syndrome (AIDS)
12/2014
1HIV Infections (HIV Infection)
01/2013
1Inflammation (Inflammations)
10/2010

Drug/Important Bio-Agent (IBA)

31Chimeric Antigen ReceptorsIBA
03/2024 - 01/2014
6Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2014
6AntigensIBA
01/2022 - 01/2014
5CytokinesIBA
01/2022 - 01/2013
4ibrutinibIBA
11/2022 - 01/2016
3tisagenlecleucelIBA
02/2024 - 01/2016
3bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2024 - 01/2023
3Artificial ReceptorsIBA
01/2022 - 01/2018
3VaccinesIBA
03/2021 - 12/2014
2Bendamustine HydrochlorideFDA Link
03/2024 - 12/2023
2AntibodiesIBA
12/2023 - 03/2021
2Interferon Type IIBA
01/2023 - 01/2013
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 01/2018
2Antiviral Agents (Antivirals)IBA
01/2022 - 01/2013
2AutoantigensIBA
12/2020 - 01/2018
2Neoplasm Antigens (Tumor Antigens)IBA
01/2018 - 01/2018
2DeoxyriboseIBA
12/2014 - 10/2010
2Anti-Infective Agents (Microbicides)IBA
12/2014 - 10/2010
1CollagenIBA
04/2024
1brexucabtagene autoleucelIBA
03/2024
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
03/2024
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2024
1axicabtagene ciloleucelIBA
12/2023
1fludarabineIBA
12/2023
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2023
1MesothelinIBA
01/2023
1pomalidomideIBA
01/2023
1Lenalidomide (CC 5013)FDA Link
01/2023
1Transcription Factors (Transcription Factor)IBA
11/2022
1RNA (Ribonucleic Acid)IBA
11/2022
1venetoclaxIBA
10/2022
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2022
1Investigational DrugsIBA
01/2022
1Calcineurin InhibitorsIBA
01/2022
1Oxygen (Dioxygen)IBA
01/2022
1ChemokinesIBA
01/2022
1Prostate-Specific Antigen (Semenogelase)IBA
01/2022
1p21-Activated KinasesIBA
01/2021
1Desmoglein 3IBA
12/2020
1AutoantibodiesIBA
12/2020
1EpitopesIBA
12/2020
1Immunoglobulin G (IgG)IBA
12/2020
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2019
1B-Cell Maturation AntigenIBA
01/2018
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2018
1acalabrutinibIBA
08/2017
1Matrix Metalloproteinases (MMPs)IBA
04/2016
1Protein Isoforms (Isoforms)IBA
02/2016
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2016
1epidermal growth factor receptor VIIIIBA
02/2015
1OligodeoxyribonucleotidesIBA
10/2010
1Poly TIBA
10/2010
1Toll-Like Receptor 7IBA
10/2010

Therapy/Procedure

23Immunotherapy
04/2024 - 01/2014
19Therapeutics
03/2024 - 01/2016
2Drug Therapy (Chemotherapy)
01/2019 - 04/2016
1Secondary Prevention
02/2024
1Intravenous Infusions
01/2023
1Castration
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2020